Resultats de la cerca - Hailemichael, Yared

Peptide-based anticancer vaccines: The making and unmaking of a T-cell graveyard per Hailemichael, Yared, Overwijk, Willem W

Obtenir text complet Obtenir text complet Obtenir text complet

Cancer vaccines: Trafficking of tumor-specific T cells to tumor after therapeutic vaccination per Hailemichael, Yared, Overwijk, Willem W.

Obtenir text complet Obtenir text complet Obtenir text complet

MOUSE MODEL FOR PRE-CLINICAL STUDY OF HUMAN CANCER IMMUNOTHERAPY per Ya, Zhiya, Hailemichael, Yared, Overwijk, Willem, Restifo, Nicholas

Obtenir text complet Obtenir text complet Obtenir text complet

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model per Haymaker, Cara L., Hailemichael, Yared, Yang, Yi, Nurieva, Roza

Obtenir text complet Obtenir text complet Obtenir text complet

Reversing gp100/IFA-induced impairment of anti-CTLA-4 checkpoint blockade therapy per Hailemichael, Yared, Fu, Tihui, Khong, Hiep, Dai, Zhimin, Sharma, Padmanee, Overwijk, Willem W

Obtenir text complet Obtenir text complet

Soluble Interleukin-15 Complexes Are Generated In Vivo by Type I Interferon Dependent and Independent Pathways per Anthony, Scott M., Howard, Megan E., Hailemichael, Yared, Overwijk, Willem W., Schluns, Kimberly S.

Obtenir text complet Obtenir text complet Obtenir text complet

ANTI-TUMOR ACTIVITY MEDIATED BY CpG: THE ROUTE OF ADMINISTRATION IS CRITICAL per Lou, Yanyan, Liu, Chengwen, Lizée, Gregory, Peng, Weiyi, Xu, Chunyu, Ye, Yang, Rabinovich, Brian A., Hailemichael, Yared, Gelbard, Alexander, Zhou, Dapeng, Overwijk, Willem W., Hwu, Patrick

Obtenir text complet Obtenir text complet Obtenir text complet

Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma in vivo and synergizes with chemotherapy per Sikora, Andrew G., Gelbard, Alexander, Davies, Michael A., Sano, Daisuke, Ekmekcioglu, Suhendan, Kwon, John, Hailemichael, Yared, Jayaraman, Padmini, Myers, Jeffrey N., Grimm, Elizabeth A., Overwijk, Willem W.

Obtenir text complet Obtenir text complet Obtenir text complet

Interferon-α enhances peptide vaccine-induced CD8(+) T cell numbers, effector function, and anti-tumor activity per Sikora, Andrew G., Jaffarzad, Nina, Hailemichael, Yared, Gelbard, Alexander, Stonier, Spencer W., Schluns, Kimberly S., Frasca, Loredana, Lou, Yanyan, Liu, Chengwen, Andersson, Helen A., Hwu, Patrick, Overwijk, Willem W.

Obtenir text complet Obtenir text complet Obtenir text complet

Peptide vaccine formulation controls the duration of antigen presentation and magnitude of tumor-specific CD8+ T cell response per Khong, Hiep, Volmari, Annika, Sharma, Meenu, Dai, Zhimin, Imo, Chinonye S., Hailemichael, Yared, Singh, Manisha, Moore, Derek T., Xiao, Zhilan, Huang, Xue-fei, Horvath, Thomas D., Hawke, David H., Overwijk., Willem W.

Obtenir text complet Obtenir text complet Obtenir text complet

Tumor-expressed iNOS controls induction of functional myeloid derived suppressor cells (MDSC) through modulation of VEGF release() per Jayaraman, Padmini, Parikh, Falguni, Lopez-Rivera, Esther, Hailemichael, Yared, Clark, Amelia, Ma, Ge, Cannan, David, Ramacher, Marcel, Kato, Masashi, Overwijk, Willem W., Chen, Shu-Hsia, Umansky, Viktor Y., Sikora, Andrew G.

Obtenir text complet Obtenir text complet Obtenir text complet

Generation of a novel therapeutic peptide that depletes MDSC in tumor-bearing mice per Qin, Hong, Lerman, Beatrisa, Sakamaki, Ippei, Wei, Guowei, Cha, Soungchul, Rao, Sheetal S., Qian, Jianfei, Hailemichael, Yared, Nurieva, Roza, Dwyer, Karen C., Roth, Johannes, Yi, Qing, Overwijk, Willem W., Kwak, Larry W.

Obtenir text complet Obtenir text complet Obtenir text complet

Inhibition of p-STAT3 Enhances IFN-α Efficacy Against Metastatic Melanoma in a Murine Model per Kong, Ling-Yuan, Gelbard, Alexander, Wei, Jun, Reina-Ortiz, Chantal, Wang, Yongtao, Yang, Eric C., Hailemichael, Yared, Fokt, Izabela, Jayakumar, Arumugam, Qiao, Wei, Fuller, Gregory N., Overwijk, Willem W., Priebe, Waldemar, Heimberger, Amy B.

Obtenir text complet Obtenir text complet Obtenir text complet

Multifaceted role of BTLA in the control of CD8(+) T cell fate after antigen encounter per Ritthipichai, Krit, Haymaker, Cara L., Martinez, Melisa, Aschenbrenner, Andrew, Yi, Xiaohui, Zhang, Minying, Kale, Charuta, Vence, Luis M., Roszik, Jason, Hailemichael, Yared, Overwijk, Willem W., Varadarajan, Navin, Nurieva, Roza, Radvanyi, Laszlo G., Hwu, Patrick, Bernatchez, Chantale

Obtenir text complet Obtenir text complet Obtenir text complet

Absence of Grail promotes CD8(+) T cell anti-tumour activity per Haymaker, Cara, Yang, Yi, Wang, Junmei, Zou, Qiang, Sahoo, Anupama, Alekseev, Andrei, Singh, Divyendu, Ritthipichai, Krit, Hailemichael, Yared, Hoang, Oanh N., Qin, Hong, Schluns, Kimberly S., Wang, Tiejun, Overwijk, Willem W., Sun, Shao-Cong, Bernatchez, Chantale, Kwak, Larry W., Neelapu, Sattva S., Nurieva, Roza

Obtenir text complet Obtenir text complet Obtenir text complet

The glutaminase inhibitor CB-839 (Telaglenastat) enhances the anti-melanoma activity of T cell mediated immunotherapies. per Varghese, Sruthy, Pramanik, Snigdha, Williams, Leila J., Hodges, Hannah R., Hudgens, Courtney W., Fischer, Grant M., Luo, Catherine K., Knighton, Barbara, Tan, Lin, Lorenzi, Philip L., Mackinnon, Andrew L., McQuade, Jennifer L., Hailemichael, Yared, Roszik, Jason, Peng, Weiyi, Vashisht Gopal, Y. N.

Obtenir text complet Obtenir text complet Obtenir text complet

Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion per Hailemichael, Yared, Dai, Zhimin, Jaffarzad, Nina, Ye, Yang, Medina, Miguel A, Huang, Xue-Fei, Dorta-Estremera, Stephanie M, Greeley, Nathaniel R, Nitti, Giovanni, Peng, Weiyi, Liu, Chengwen, Lou, Yanyan, Wang, Zhiqiang, Ma, Wencai, Rabinovich, Brian, Schluns, Kimberly S, Davis, Richard E, Hwu, Patrick, Overwijk, Willem W

Obtenir text complet Obtenir text complet Obtenir text complet

Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain per Singh, Manisha, Vianden, Christina, Cantwell, Mark J., Dai, Zhimin, Xiao, Zhilan, Sharma, Meenu, Khong, Hiep, Jaiswal, Ashvin R., Faak, Faisal, Hailemichael, Yared, Janssen, L. M. E., Bharadwaj, Uddalak, Curran, Michael A., Diab, Adi, Bassett, Roland L., Tweardy, David J., Hwu, Patrick, Overwijk, Willem W.

Obtenir text complet Obtenir text complet Obtenir text complet

Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy per Hailemichael, Yared, Woods, Amber, Fu, Tihui, He, Qiuming, Nielsen, Michael C., Hasan, Farah, Roszik, Jason, Xiao, Zhilan, Vianden, Christina, Khong, Hiep, Singh, Manisha, Sharma, Meenu, Faak, Faisal, Moore, Derek, Dai, Zhimin, Anthony, Scott M., Schluns, Kimberly S., Sharma, Padmanee, Engelhard, Victor H., Overwijk, Willem W.

Obtenir text complet Obtenir text complet Obtenir text complet

Protein Targeting Chimeric Molecules Specific for Bromodomain and Extra-terminal Motif Family Proteins are Active Against Pre-Clinical Models of Multiple Myeloma per Zhang, Xiaohui, Lee, Hans C., Shirazi, Fazal, Baladandayuthapani, Veerabhadran, Lin, Heather, Kuiatse, Isere, Wang, Hua, Jones, Richard J., Berkova, Zuzana, Singh, Ram Kumar, Lu, Jing, Qian, Yimin, Raina, Kanak, Coleman, Kevin G., Crews, Craig M., Li, Bingzong, Wang, Huihan, Hailemichael, Yared, Thomas, Sheeba K., Wang, Zhiqiang, Davis, R. Eric, Orlowski, Robert Z.

Obtenir text complet Obtenir text complet Obtenir text complet